[News] TACE plus external beam radiotherapy in liver cancer

New research suggests that combined treatment with transarterial chemoembolization (TACE) and external beam radiotherapy improves survival outcomes compared with sorafenib —the standard systemic therapy—in patients with hepatocellular carcinoma.

Source: The Lancet Oncology - March 22, 2018 Category: Cancer & Oncology Authors: Manjulika Das Tags: News Source Type: research